Perphenazine
-
Subject Areas on Research
- Comparison of outcomes for African Americans, Hispanics, and Non-Hispanic Whites in the CATIE study.
- Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia.
- Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
- Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.
- Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study.
- Employment outcomes in a randomized trial of second-generation antipsychotics and perphenazine in the treatment of individuals with schizophrenia.
- Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1.
- Impact of second-generation antipsychotics and perphenazine on depressive symptoms in a randomized trial of treatment for chronic schizophrenia.
- Introduction to the CATIE special section.
- Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
- Randomized Trial of the Effect of Four Second-Generation Antipsychotics and One First-Generation Antipsychotic on Cigarette Smoking, Alcohol, and Drug Use in Chronic Schizophrenia.
- Results of phase 3 of the CATIE schizophrenia trial.
- The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study.
- The effects of antipsychotic medications on emotion perception in patients with chronic schizophrenia in the CATIE trial.
- Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia.
- Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia.
- What CATIE found: results from the schizophrenia trial.